全球ATP检测市场规模、份额、趋势和成长分析报告（2026-2034年）

预计 ATP 检测市场将从 2025 年的 9.7 亿美元成长到 2034 年的 20 亿美元，2026 年至 2034 年的复合年增长率为 8.29%。

受製药、生物技术和食品安全产业对快速污染检测和细胞活力检测需求不断增长的推动，全球ATP检测市场持续稳定扩张。药物研发投入的增加以及医疗机构对卫生监测日益重视，也进一步提升了市场渗透率。由于ATP检测能够快速、灵敏、可靠地检测生物残留物，因此在全球范围内，它已成为品管和微生物检测领域极具价值的技术。

关键成长要素包括严格的卫生管理和感染控制监管标准，特别是在医院和食品加工环境中。生物製药生产和细胞研究的激增进一步增加了对基于ATP的发光检测的需求。携带式发光仪和自动化检测平台等技术进步正在提高效率，并扩大新兴经济体的应用范围。

展望未来，亚太地区生命科学研发投入的增加和製药业的扩张预计将为市场发展提供强劲动力。发展中地区对快速卫生监测解决方案的日益重视也将创造新的机会。 ATP检测与数位资料管理系统和自动化技术的整合将提高工作流程效率，并促进市场的永续长期成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球ATP检测市场：依产品划分

• 市场分析、洞察与预测
• 耗材和配件
• 试剂
• 微孔盘
• 其他耗材和配件
• 装置
• 发光计
• 光强度

第五章：全球ATP检测市场：按应用划分

• 市场分析、洞察与预测
• 污染测试
• 疾病检测
• 药物发现与开发

第六章：全球ATP检测市场：依最终用户划分

• 市场分析、洞察与预测
• 製药和生物技术公司
• 食品饮料业
• 医院/诊断检查室
• 学术研究机构

第七章 全球ATP检测市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific Inc
  • Promega Corporation
  • Merck KGaA
  • PerkinElmer Inc
  • Agilent Technologies Inc
  • Abcam Plc
  • Lonza Group
  • Neogen Corporation
  • 3M
  • Danaher Corporation
  • PromoCell GmbH
  • Geno Technology Inc
  • Abnova Corporation
  • AAT Bioquest Inc
  • BioThema AB

The ATP Assays Market size is expected to reach USD 2.00 Billion in 2034 from USD 0.97 Billion (2025) growing at a CAGR of 8.29% during 2026-2034.

The Global ATP Assays Market is witnessing steady expansion driven by rising demand for rapid contamination detection and cellular viability testing across pharmaceutical, biotechnology, and food safety industries. Increasing R&D investments in drug discovery and growing focus on hygiene monitoring in healthcare facilities are strengthening market penetration. ATP assays offer quick, sensitive, and reliable detection of biological residues, making them highly valuable in quality control and microbial testing applications worldwide.

Key growth drivers include stringent regulatory standards for sanitation and infection control, particularly in hospitals and food processing environments. The surge in biologics production and cell-based research has further elevated demand for ATP-based luminescence assays. Technological advancements such as portable luminometers and automated detection platforms are enhancing efficiency and expanding adoption across emerging economies.

Looking ahead, the market is expected to benefit from rising investments in life sciences research and expanding pharmaceutical manufacturing in Asia-Pacific. Growing awareness of rapid hygiene monitoring solutions in developing regions will create additional opportunities. Integration of ATP assays with digital data management systems and automation is likely to improve workflow efficiency, positioning the market for sustainable long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Consumables & Accessories
• Reagent
• Microplates
• Other Consumables & Accessories
• Instruments
• Luminometers
• Spectrophotometers

By Application

• Contamination Testing
• Disease Testing
• Drug Discovery and Development

By End User

• Pharmaceutical & Biotechnology companies
• Food and Beverage Industry
• Hospitals and Diagnostic Laboratories
• Academic and Research Institutions

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Promega Corporation, Merck KGaA, PerkinElmer Inc, Agilent Technologies Inc, Abcam plc, Lonza Group, Neogen Corporation, 3M, Danaher Corporation, PromoCell GmbH, Geno Technology Inc, Abnova Corporation, AAT Bioquest Inc, BioThema AB
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ATP ASSAYS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Consumables & Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagent Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Microplates Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Consumables & Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Luminometers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Spectrophotometers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ATP ASSAYS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Contamination Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Drug Discovery and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ATP ASSAYS MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Pharmaceutical & Biotechnology companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Food and Beverage Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hospitals and Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Academic and Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ATP ASSAYS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ATP ASSAYS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Promega Corporation
  • 9.2.3 Merck KGaA
  • 9.2.4 PerkinElmer Inc
  • 9.2.5 Agilent Technologies Inc
  • 9.2.6 Abcam Plc
  • 9.2.7 Lonza Group
  • 9.2.8 Neogen Corporation
  • 9.2.9 3M
  • 9.2.10 Danaher Corporation
  • 9.2.11 PromoCell GmbH
  • 9.2.12 Geno Technology Inc
  • 9.2.13 Abnova Corporation
  • 9.2.14 AAT Bioquest Inc
  • 9.2.15 BioThema AB